BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37692950)

  • 1. A pan-cancer analysis of pituitary tumor-transforming 3, pseudogene.
    Li J; Shaikh SN; Uqaili AA; Nasir H; Zia R; Akram MA; Jawad FA; Sohail S; AbdelGawwad MR; Almutairi SM; Elshikh MS; Jamil M; Rasheed RA
    Am J Transl Res; 2023; 15(8):5408-5424. PubMed ID: 37692950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of the oncogenic role of FAM83D across cancers based on data mining.
    Geng Y; Liu J; Wang Z; Liu T; Peng X; Huang Y
    Cell Cycle; 2023 Apr; 22(8):1005-1019. PubMed ID: 36710419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer.
    Mi J; Luo J; Zeng H; Zhang H; Jamil M; Abdel-Maksoud MA; Zakri AM; Alfuraydi AA; Zhang N; Xiao M
    Am J Transl Res; 2023; 15(10):6026-6041. PubMed ID: 37969191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analysis reveals methylenetetrahydrofolate dehydrogenase 1-like as an independent shared diagnostic and prognostic biomarker in five different human cancers.
    Sial N; Rehman JU; Saeed S; Ahmad M; Hameed Y; Atif M; Rehman A; Asif R; Ahmed H; Hussain MS; Khan MR; Ambreen A; Ambreen A
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34908119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human Cancer.
    Sial N; Saeed S; Ahmad M; Hameed Y; Rehman A; Abbas M; Asif R; Ahmed H; Hussain MS; Rehman JU; Atif M; Khan MR
    Int J Gen Med; 2021; 14():7025-7042. PubMed ID: 34707394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Oncogenic Roles of
    Grzechowiak I; Graś J; Szymańska D; Biernacka M; Guglas K; Poter P; Mackiewicz A; Kolenda T
    Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32824814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pseudogene PTTG3P Promotes Cell Migration and Invasion in Esophageal Squamous Cell Carcinoma.
    Zhang Z; Shi Z
    Open Med (Wars); 2019; 14():516-522. PubMed ID: 31346548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pan-cancer analysis of GINS complex subunit 4 to identify its potential role as a biomarker in multiple human cancers.
    Usman M; Okla MK; Asif HM; AbdElgayed G; Muccee F; Ghazanfar S; Ahmad M; Iqbal MJ; Sahar AM; Khaliq G; Shoaib R; Zaheer H; Hameed Y
    Am J Cancer Res; 2022; 12(3):986-1008. PubMed ID: 35411239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding SEC24 Homolog D, COPII coat complex component accuracy as a signature gene in three human cancers.
    Du W; Sun Y; Ji W; Luo T; Zhang D; Guo W; Liang J; Lv Y; Dong M; Li K
    Am J Cancer Res; 2023; 13(8):3686-3704. PubMed ID: 37693152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Expression of Pseudogene PTTG3P Indicates a Poor Prognosis in Human Breast Cancer.
    Lou W; Ding B; Fan W
    Mol Ther Oncolytics; 2019 Sep; 14():15-26. PubMed ID: 31011629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers.
    Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS
    Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma.
    Hu Y; Chen J; Liu M; Feng Q; Peng H
    Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36281789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma.
    Gao W; Zhang ZW; Wang HY; Li XD; Peng WT; Guan HY; Liao YX; Liu A
    Front Genet; 2022; 13():895281. PubMed ID: 35754792
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of hub genes associated with head and neck squamous cell carcinoma by integrated bioinformatics approach and RNA-seq validation analysis.
    Shabeer A; Mustafa S; Bukhari RS; Abdel-Maksoud MA; Almutairi SM; Al-Qahtani WH; Chandio K; Khan NY; Gul J; Aufy M
    Am J Cancer Res; 2023; 13(4):1259-1277. PubMed ID: 37168331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of four signature genes for clinical testing through bioinformatics and in vitro methods in head and neck squamous cell carcinoma.
    Javed M; Bukhari RS; Rasool R; Alhomrani M; Alghamdi SA; Habeeballah H; Ramzan F; Baothman BK; Kashif M; Almaghrabi S; Izmirly AM; Khalid SY
    Am J Cancer Res; 2023; 13(5):1826-1844. PubMed ID: 37293145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.
    Wu K; Zhang C; Zhang C; Dai D
    Biomed Res Int; 2020; 2020():5973082. PubMed ID: 32104700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTTG3P promotes gastric tumour cell proliferation and invasion and is an indicator of poor prognosis.
    Weng W; Ni S; Wang Y; Xu M; Zhang Q; Yang Y; Wu Y; Xu Q; Qi P; Tan C; Huang D; Wei P; Huang Z; Ma Y; Zhang W; Sheng W; Du X
    J Cell Mol Med; 2017 Dec; 21(12):3360-3371. PubMed ID: 28631396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation.
    Feng Y; Zhou YH; Zhao J; Su XL; Chen NX; Zhao YQ; Ye Q; Hu J; Ou-Yang ZY; Zhong MM; Yang YF; Han PJ; Guo Y; Feng YZ
    Front Genet; 2023; 14():1041042. PubMed ID: 36936420
    [No Abstract]   [Full Text] [Related]  

  • 20. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.